CTA
IRMD icon

Colonial Trust Advisors’s iRadimed IRMD Stock Holding History

Colonial Trust Advisors’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.41K Hold
25
– – ﹤0.01% 653
2025
Q4 		$2.43K Buy
+25
New +$2.15K ﹤0.01% 630

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Colonial Trust Advisors's IRMD Position: Q1 2026 in Review

Colonial Trust Advisors held its iRadimed (IRMD) position steady in Q1 2026 at 25 shares worth $2.41K. The position accounts for ﹤0.01% of the portfolio, ranked #653.

Colonial Trust Advisors first reported a position in IRMD in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.43K in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Colonial Trust Advisors held 25 shares of iRadimed worth $2.41K as of Q1 2026.
  • Colonial Trust Advisors left its iRadimed share count unchanged in Q1 2026.
  • iRadimed made up ﹤0.01% of Colonial Trust Advisors's portfolio in Q1 2026, its #653 holding.
  • Colonial Trust Advisors first reported a position in iRadimed in Q4 2025 and has held it in 2 quarters since.
  • Colonial Trust Advisors's iRadimed position peaked at $2.43K in Q4 2025.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Colonial Trust Advisors's 13F filing for Q1 2026, filed 12 May 2026.